News

Adaptive Clinical Protocol Design for Phase II MPox Clade I Treatment with a Novel Broad-Spectrum Drug NV-387 is Almost Complete, Reports NanoViricides
SHELTON, CT / ACCESS Newswire / July 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of bro ...
Global Vaccines
Find Global Vaccines Latest News, Videos & Pictures on Global Vaccines and see latest updates, news, information from NDTV.COM. Explore more on Global Vaccines.